MedPath

MILPRO CHEWY

MILPROCHEWY (milbemycin oxime/praziquantel)

Approved
Approval ID

7d993f88-8af9-4668-bd09-40d553af5072

Product Type

PRESCRIPTION ANIMAL DRUG LABEL

Effective Date

Jun 11, 2025

Manufacturers
FDA

Virbac AH Inc

DUNS: 131568396

Products 6

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-088
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 25.0 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 250 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-091
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 25 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 250 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-090
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 12.5 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 125 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-087
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 12.5 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 125 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-086
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 2.5 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 25 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

milbemycin oxime/praziquantel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51311-089
Product Classification
G
Generic Name
milbemycin oxime/praziquantel
Product Specifications
Route of AdministrationORAL
Effective DateJune 11, 2025
FDA Product Classification

INGREDIENTS (2)

MILBEMYCIN OXIMEActive
Quantity: 2.5 mg in 1 1
Code: 0502PUN0GT
Classification: ACTIB
PRAZIQUANTELActive
Quantity: 25 mg in 1 1
Code: 6490C9U457
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 6/18/2025

Labels

image description

image description

image description

image description

image description

image descriptionimage description

image description

image description

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.